A businesswoman-turned-politician has denied allegations that her company, Pharmally Biological and Pharmaceutical Company (PBPC), is connected with the controversial firm Pharmally Pharmaceutical Corporation (PPC), which is currently the subject of an investigation by the Senate blue ribbon committee.

In a statement, Rose Lin, who is running in the 2022 elections, said she has no links with the controversial Pharmally Pharmaceuticals which is accused of entering into an allegedly questionable multi-billion transaction with the government involving the distribution of medical supplies to fight coronavirus disease 2019 (Covid-19).